Scholarlink

Objective <p>The 1357&#xa0;bp deletion is a rare type of β-thalassemia, and the literature on its characterization is very limited. This study aimed to conduct molecular diagnosis and clinical analysis of a 1357&#xa0;bp deletion in the Guangxi cohort.</p> Methods <p>This was a retrospective study in which all samples with Hb F &gt; 5% and/or Hb A<sub>2</sub> &gt; 3.5% suspected of β-thalassemia/hereditary persistence of fetal hemoglobin (HPFH) were enrolled in the study from 2016 to 2024. Routine genetic analysis was detected 24 common α- and β-thalassemia variants. For unresolved cases, Sanger sequencing was applied to identify novel variants in <i>HBB</i> and <i>HBG</i> genes. Additionally, Gap-PCR with specific primers and multiplex ligation-dependent probe amplification (MLPA) were utilized to screen for potential deletions. Finally, third-generation sequencing (TGS) was implemented to confirm duplicated genomic segments.</p> Results <p>A cohort of 65 individuals was analyzed, revealing heterozygous β-thalassemia/HPFH/δβ-thalassemia in 83.1% (54/65) of cases. Among these, 37.0% (20/54) carried the 1357&#xa0;bp deletion, 46.3% (25/54) exhibited Chinese <sup>G</sup>γ(Aγδβ)⁰-thalassemia, and 16.7% (9/54) displayed SEA-HPFH. Genotypic analysis of the 1357&#xa0;bp deletion showed four distinct profiles: simple heterozygotes (75%, 15/20), compound heterozygotes with α-thalassemia (15%, 3/20), compound heterozygotes with β-thalassemia (5%, 1/20), and compound heterozygotes with HPFH (5%, 1/20). Hematologically, the 1357&#xa0;bp deletion presented with microcytic, hypochromic erythrocytes alongside elevated Hb A<sub>2</sub> and Hb F levels. Geographically, Beihai City (70%, 14/20) demonstrated the highest prevalence of this deletion within the Guangxi region.</p> Conclusion <p>This study provides the first comprehensive characterization of the 1357&#xa0;bp deletion, delineating its hematological profiles, molecular features, and region-specific prevalence patterns within the Guangxi Region. Accurate identification of molecular defects through phenotype-genotype correlation is important for genetic counseling and prenatal diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The 1357 bp deletion in β-thalassemia: molecular profiling and hematological characterization in a Guangxi cohort

  • 期刊论文

  • 发表日期：

    2025年6月16日

查看全文
  • Youqiong Li,
  • Tianjie Zhou,
  • Lihua Ye,
  • Liang Liang,
  • Shufu Cheng,
  • Lihong Zheng,
  • Xi He,
  • Peixing Wan,
  • Tongfeng Huang

摘要

Objective

The 1357 bp deletion is a rare type of β-thalassemia, and the literature on its characterization is very limited. This study aimed to conduct molecular diagnosis and clinical analysis of a 1357 bp deletion in the Guangxi cohort.

Methods

This was a retrospective study in which all samples with Hb F > 5% and/or Hb A2 > 3.5% suspected of β-thalassemia/hereditary persistence of fetal hemoglobin (HPFH) were enrolled in the study from 2016 to 2024. Routine genetic analysis was detected 24 common α- and β-thalassemia variants. For unresolved cases, Sanger sequencing was applied to identify novel variants in HBB and HBG genes. Additionally, Gap-PCR with specific primers and multiplex ligation-dependent probe amplification (MLPA) were utilized to screen for potential deletions. Finally, third-generation sequencing (TGS) was implemented to confirm duplicated genomic segments.

Results

A cohort of 65 individuals was analyzed, revealing heterozygous β-thalassemia/HPFH/δβ-thalassemia in 83.1% (54/65) of cases. Among these, 37.0% (20/54) carried the 1357 bp deletion, 46.3% (25/54) exhibited Chinese Gγ(Aγδβ)⁰-thalassemia, and 16.7% (9/54) displayed SEA-HPFH. Genotypic analysis of the 1357 bp deletion showed four distinct profiles: simple heterozygotes (75%, 15/20), compound heterozygotes with α-thalassemia (15%, 3/20), compound heterozygotes with β-thalassemia (5%, 1/20), and compound heterozygotes with HPFH (5%, 1/20). Hematologically, the 1357 bp deletion presented with microcytic, hypochromic erythrocytes alongside elevated Hb A2 and Hb F levels. Geographically, Beihai City (70%, 14/20) demonstrated the highest prevalence of this deletion within the Guangxi region.

Conclusion

This study provides the first comprehensive characterization of the 1357 bp deletion, delineating its hematological profiles, molecular features, and region-specific prevalence patterns within the Guangxi Region. Accurate identification of molecular defects through phenotype-genotype correlation is important for genetic counseling and prenatal diagnosis.